Jack Talley, Chief Executive Officer, will present at the 18th Annual BIO CEO & INVESTOR conference taking place on February 8-9, 2016 at the Waldorf Astoria Hotel in New York City.
Mr. Talley’s presentation will take place on Tuesday, February 9 at 9:30 AM EST in the Park North room in the multiple therapeutics track of the conference. The presentation will be webcast and can be accessed via the following link:
An archived webcast will be available on the Izun website (www,izunpharma.com) for 90 days following the presentation.
Mr. Talley will be presenting important new data from the analysis of the recently completed randomized double blind clinical trial of Curasite™ in the treatment of chronic diabetic foot ulcers. He will also update the double blind placebo controlled ongoing study of IZN-OM to prevent the development of oral mucositis in solid tumor cancer patients.